In vivo Efficacy Model for Cancer Research
Increase the predictivity of drug discovery
HOW IT WORKS
Companion animals can be used as a informative model in the preclinical development and discovery of novel cancer treatment.
Studies in dogs provide guidance for conducting similar investigation in human patients.
This model helps to evaluate the efficacy and feasibility of new compounds and can inform the GO/NO-GO decision in clinical drug development.
Selected compound with anti-cancer activity demonstrated in vitro and mice studies
We design and conduct
companion animals trials in
our veterinary international
Examples of Preclinical Investigation in Companion Animals
Are you having problem to translate results from mice to human?
Less than 8% of compounds tested in mice models pass successfully human phase I clinical trial
Learn how our In vivo Efficacy Model for Cancer Research can increase the predictivity of drug discovery
Get in touch
Lucas Rodrigues, DVM, MS, PhD
CEO & Scientific Director
Mauricio Bauer, DVM, BVSc.,MBA
Francisco Scacchetti, BBA
Chief Financial Officer
505 S. Rosa Road, Suite 225
Madison, WI 53719